Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saturation Genome Editing reveals the functional impact of RAD51D <i>and</i> XRCC2 variants.

bioRxiv : the preprint server for biology·2026
Same author

Embryo-scale Visual Cell Sorting reveals a conserved transcriptomic signature of nucleolar size linked to proteostasis.

bioRxiv : the preprint server for biology·2026
Same author

Evidence for G6PD variant classification from multiplexed functional assays.

Genome biology·2026
Same author

Phenotype-Specific Recalibration of MAVE Data Enables Repurposing of <i>BAP1</i> Functional Assays for Küry-Isidor Syndrome.

medRxiv : the preprint server for health sciences·2026
Same author

Not Forgotten: Patient Experiences with Genetic Variant Reclassifications.

medRxiv : the preprint server for health sciences·2026
Same author

Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effects.

Cell·2026
Same journal

Navigating the Computational Landscape for Drug Repurposing.

Annual review of pharmacology and toxicology·2026
Same journal

Microplastics and Atherosclerosis: Mechanisms.

Annual review of pharmacology and toxicology·2026
Same journal

Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology.

Annual review of pharmacology and toxicology·2026
Same journal

<i>Caenorhabditis elegans</i> as a Model System for Environmental Mitotoxicants.

Annual review of pharmacology and toxicology·2025
Same journal

Introduction to the Theme "New Approaches, Technology, and Techniques That Advance Pharmacology and Toxicology".

Annual review of pharmacology and toxicology·2025
Same journal

A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of <i>Staphylococcus aureus</i>.

Annual review of pharmacology and toxicology·2025
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

39.3K

Measuring Pharmacogene Variant Function at Scale Using Multiplexed Assays.

Renee C Geck1, Gabriel Boyle1, Clara J Amorosi1

  • 1Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA; email: dfowler@uw.edu, maitreya@uw.edu.

Annual Review of Pharmacology and Toxicology
|September 13, 2021
PubMed
Summary
This summary is machine-generated.

Multiplexed assays now experimentally measure the function of thousands of genetic variants simultaneously. This advance is crucial for understanding pharmacogenomics and guiding personalized drug selection and dosing.

Keywords:
deep mutational scanmultiplexed assay of variant effectnext-generation sequencingpharmacogenomicsprecision medicinevariable drug response

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.3K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Related Experiment Videos

Last Updated: Oct 20, 2025

Infinium Assay for Large-scale SNP Genotyping Applications
13:33

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

39.3K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.3K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.1K

Area of Science:

  • Genomics
  • Pharmacogenomics
  • Molecular Biology

Background:

  • Genetic variant identification via next-generation sequencing outpaces functional consequence understanding.
  • This knowledge gap hinders pharmacogenomics' goal of personalized drug therapy.
  • Multiplexed assays offer a solution for high-throughput variant functional analysis.

Purpose of the Study:

  • To describe multiplexed assays for measuring the functional impact of genetic variants.
  • To detail experimental design advancements for these assays.
  • To explore challenges in utilizing multiplexed functional data for pharmacogenomics.

Main Methods:

  • Development and application of multiplexed assays for variant effect.
  • Simultaneous experimental measurement of nearly 25,000 variants.
  • Focus on eight key pharmacogenes (e.g., CYP2C9, VKORC1) and the LDLR promoter.

Main Results:

  • Successful implementation of multiplexed assays across a large number of pharmacogene variants.
  • Demonstration of a scalable approach to assess variant function.
  • Identification of areas for methodological improvement in assay design and data interpretation.

Conclusions:

  • Multiplexed assays are a powerful tool for elucidating pharmacogene variant function.
  • Addressing current challenges will enhance the clinical utility of pharmacogenomics.
  • This approach accelerates the translation of genetic discoveries into improved patient care.